RNA-catalysed RNA methylation was recently shown to be part of the catalytic repertoire of ribozymes. The methyltransferase ribozyme MTR1 catalyses the site-specific synthesis of 1-methyladenosine (m\(^1\)A) in RNA, using O\(^6\)-methylguanine (m\(^6\)G) as methyl group donor. Here we report the crystal structure of MTR1 at a resolution of 2.8 Å, which reveals a guanine binding site reminiscent of natural guanine riboswitches. The structure represents the postcatalytic state of a split ribozyme in complex with the m1A-containing RNA product and the demethylated cofactor guanine. The structural data suggest the mechanistic involvement of a protonated cytidine in the methyl transfer reaction. A synergistic effect of two 2'-O-methylated ribose residues in the active site results in accelerated methyl group transfer. Supported by these results, it seems plausible that modified nucleotides may have enhanced early RNA catalysis and that metabolite-binding riboswitches may resemble inactivated ribozymes that have lost their catalytic activity during evolution.

In this work, the influence of aromatic structures on drug encapsulation, self-assembly and hydrogel formation was investigated. The physically crosslinked gelling systems were characterized and optimized for the use in biofabrication and applied in initial (bio)printing experiments. Chapter I: The cytocompatible (first in vitro and in vivo studies) amphiphile PMeOx-b-PBzOx-b- PMeOx (A-PBzOx-A) was used for the solubilization of PTX, schizandrin A (SchA), curcumin (CUR), niraparib and HS-173. Chapter II: Compared to the polymers A-PPheOx-A, A-PBzOx-A and A-PBzOzi-A, only the polymer A-PPheOzi-A showed a reversible temperature- and concentration-dependent inverse thermogelation, which is accompanied by a morphology change from long wormlike micelles in the gel to small spherical micelles in solution. The worm formation results from novel interactions between the hydrophilic and hydrophobic aromatic polymer blocks. Changes in the hydrophilic block significantly alter the gel system. Rheological properties can be optimized by concentration and temperature, which is why the hydrogel was used to significantly improve the printability and stability of Alg in a blend system. Chapter III: By extending the side chain of the aromatic hydrophobic block, the inverse thermogelling polymer A-poly(2-phenethyl-2-oxazoline)-A (A-PPhenEtOx-A) is obtained. Rapid gelation upon cooling is achieved by inter-correlating spherical micelles. Based on ideal rheological properties, first cytocompatible bioprinting experiments were performed in combination with Alg. The polymers A- poly(2-benzhydryl-2-oxazoline)-A (A-PBhOx-A) and A-poly(2-benzhydryl-2-oxazine) (A-PBhOzi-A) are characterized by two aromatic benzyl units per hydrophobic repeating unit. Only the polymer A- PBhOzi-A exhibited inverse thermogelling behavior. Merging micelles could be observed by electron microscopy. The system was rheologically characterized and discussed with respect to an application in 3D printing. Chapter IV: The thermogelling POx/POzi system, in particular the block copolymer PMeOx-b- PnPrOzi, was used in different applications in the field of biofabrication. The introduction of maleimide and furan units along the hydrophilic polymer part ensured additional stabilization by Diels-Alder crosslinking after the printing process.

Most drugs are no longer produced in their own countries by the pharmaceutical companies, but by contract manufacturers or at manufacturing sites in countries that can produce more cheaply. This not only makes it difficult to trace them back but also leaves room for criminal organizations to fake them unnoticed. For these reasons, it is becoming increasingly difficult to determine the exact origin of drugs. The goal of this work was to investigate how exactly this is possible by using different spectroscopic methods like nuclear magnetic resonance and near- and mid-infrared spectroscopy in combination with multivariate data analysis. As an example, 56 out of 64 different paracetamol preparations, collected from 19 countries around the world, were chosen to investigate whether it is possible to determine the pharmaceutical company, manufacturing site, or country of origin. By means of suitable pre-processing of the spectra and the different information contained in each method, principal component analysis was able to evaluate manufacturing relationships between individual companies and to differentiate between production sites or formulations. Linear discriminant analysis showed different results depending on the spectral method and purpose. For all spectroscopic methods, it was found that the classification of the preparations to their manufacturer achieves better results than the classification to their pharmaceutical company. The best results were obtained with nuclear magnetic resonance and near-infrared data, with 94.6%/99.6% and 98.7/100% of the spectra of the preparations correctly assigned to their pharmaceutical company or manufacturer.

In dieser Dissertation werden die Umgebungseinflüsse auf die strukturellen und elektronischen Eigenschaften von verschiedenen offen- und geschlossenschaligen Systemen mittels quantenchemischer Methoden berechnet. Ein Kernpunkt umfasst die Untersuchung von verdreht angeordneten, biradikalischen Diborylalkenen, welche eine ungesättigte C2R2-Brücke (R = Et, Me) besitzen und durch cyclische (Alkyl)(amino)carbene (CAACs) stabilisiert werden. Quantenchemische Berechnungen zeigen, dass hauptsächlich sterische Effekte für die Ausbildung einer verdrehten Molekülanordnung verantwortlich sind, während bei geringen sterischen Wechselwirkungen (R = H) die Delokalisationseffekte überwiegen, wodurch eine planare Struktur begünstigt wird. Die Bevorzugung einer offenschaligen Singulettkonfiguration anstelle eines Tripletts ist auf den großen Energieunterschied der beiden einfach besetzten Molekülorbitale zurückzuführen. Durch die Berechnung der Lösungsmitteleffekte mithilfe von polarisierbaren Kontinuumsmodellen kann gefolgert werden, dass mit zunehmender statischer Dielektrizitätskonstante eine planare und geschlossenschalige Struktur stärker stabilisiert wird als eine verdrehte Anordnung. Ein weiteres Thema dieser Dissertation befasst sich mit der quantenchemischen Analyse eines makrozyklischen Perylenbisimid-Trimersystems, welches eingebettet in einer Polymethylmethacrylat-Matrix bei Temperaturen nahe dem absoluten Nullpunkt eine Lokalisierung der ersten drei angeregten Zustände zeigt. Quantenchemische Vakuumberechnungen ergeben, dass unabhängig von der gegenseitigen geometrischen Orientierung der drei Perylenbisimid-Chromophore der Übergang vom Grundzustand in den S1-Zustand verboten ist und dass die ersten drei angeregten Zustände delokalisiert vorliegen. Mithilfe von expliziten Lösungsmittelmodellen kann jedoch gezeigt werden, dass das Auftreten dieser Lokalisierungen auf eine inhomogene Polymethylmethacrylat-Umgebung zurückzuführen ist, die zu einem Symmetriebruch und somit zu einer Zunahme der Oszillatorstärke für S1 und der Lokalisierungsgrade für S1, S2 und S3 führt. Darüber hinaus wird der Lösungsmitteleinfluss auf die angeregten Zustände des Azulens mittels impliziter und expliziter Lösungsmittelmodelle berechnet. Bei einer Erhöhung der dynamischen Dielektrizitätskonstante im impliziten Modell nehmen die Anregungsenergien der vertikalen Singulettzustände ab, wobei der Effekt mit steigender Oszillatorstärke zunimmt. Die Auswirkung der statischen Dielektrizitätskonstante auf die Anregungsenergien ist dagegen deutlich schwächer ausgeprägt. Im expliziten Modell bewirkt das Lösungsmittel ebenfalls eine Abnahme der Anregungsenergie des hellen Singulettzustands, wenn auch in geringerem Umfang als im impliziten Modell. Als letztes Thema wird der Inhibitionsmechanismus der Cysteinprotease Rhodesain durch zwei modifizierte 1,4-Naphthoquinone untersucht. Während beide Naphthoquinone an der 2-Position eine Dipeptideinheit aufweisen, besitzen sie an der 3-Position entweder einen Nitril- oder Chloridsubstituenten. Zwar erfolgt bei beiden Derivaten die Inhibition über einen kovalent-reversiblen Mechanismus, jedoch verläuft die Hemmung im Falle des Nitrilderivats erheblich effektiver. Die quantenchemischen Berechnungen eines vereinfachten Modells zeigen, dass die Cysteineinheit (HS-R) bevorzugt in einer exothermen und reversiblen Additionsreaktion an die elektronenarme C-C-Doppelbindung der Naphthoquinone anlagert. Dabei werden kleinere Reaktionsenergien für die Reaktion des Chlorderivats als für die Reaktion des Nitrilderivats erhalten. Durch die Berücksichtigung von Wasser in einem impliziten Lösungsmittelmodell kommt es bei fast allen Reaktionsprodukten zu einer Energiezunahme, die bei der Reaktion des Nitrilderivats stärker ausfällt als bei der Reaktion des Chlorderivats.

The US National Research Council (NRC) report "Toxicity Testing in the 21st Century: A Vision and a strategy (Tox21)", published in 2007, calls for a complete paradigm shift in tox-icity testing. A central aspect of the proposed strategy includes the transition from apical end-points in in vivo studies to more mechanistically based in vitro tests. To support and facilitate the transition and paradigm shift in toxicity testing, the Adverse Outcome Pathway (AOP) concept is widely recognized as a pragmatic tool. As case studies, the AOP concept was ap-plied in this work to develop AOPs for proximal tubule injuries initiated by Receptor-mediated endocytosis and lysosomal overload and Inhibition of mtDNA polymerase-. These AOPs were used as a mechanistic basis for the development of in vitro assays for each key event (KE). To experimentally support the developed in vitro assays, proximal tubule cells from rat (NRK-52E) and human (RPTEC/TERT1) were treated with model compounds. To measure the dis-turbance of lysosomal function in the AOP – Receptor-mediated endocytosis and lysosomal overload, polymyxin antibiotics (polymyxin B, colistin, polymyxin B nonapeptide) were used as model compounds. Altered expression of lysosomal associated membrane protein 1/2 (LAMP-1/2) (KE1) and cathepsin D release from lysosomes (KE2) were determined by im-munofluorescence, while cytotoxicity (KE3) was measured using the CellTiter-Glo® cell via-bility assay. Importantly, significant differences in polymyxin uptake and susceptibility be-tween cell lines were observed, underlining the importance of in vitro biokinetics to determine an appropriate in vitro point of departure (PoD) for risk assessment. Compared to the in vivo situation, distinct expression of relevant transporters such as megalin and cubilin on mRNA and protein level in the used cell lines (RPTEC/TERT1 and NRK-52E) could not be con-firmed, making integration of quantitative in vitro to in vivo extrapolations (QIVIVE) neces-sary. Integration of QIVIVE by project partners of the University of Utrecht showed an im-provement in the modelled biokinetic data for polymyxin B. To assess the first key event, (KE1) Depletion of mitochondrial DNA, in the AOP – Inhibition of mtDNA polymerase-, a RT-qPCR method was used to determine the mtDNA copy number in cells treated with mod-el compounds (adefovir, cidofovir, tenofovir, adefovir dipivoxil, tenofovir disoproxil fumarate). Mitochondrial toxicity (KE2) was measured by project partners using the high-content imaging technique and MitoTracker® whereas cytotoxicity (KE3) was determined by CellTiter-Glo® cell viability assay. In contrast to the mechanistic hypothesis underlying the AOP – Inhibition of mtDNA polymerase-, treatment with model compounds for 24 h resulted in an increase rather than a decrease in mtDNA copy number (KE1). Only minor effects on mitochondrial toxicity (KE2) and cytotoxicity (KE3) were observed. Treatment of RPT-EC/TERT1 cells for 14 days showed only a slight decrease in mtDNA copy number after treatment with adefovir dipivoxil and tenofovir disoproxil fumarate, underscoring some of the limitations of short-term in vitro systems. To obtain a first estimation for risk assessment based on in vitro data, potential points of departure (PoD) for each KE were calculated from the obtained in vitro data. The most common PoDs were calculated such as the effect concentra-tion at which 10 % or 20_% effect was measured (EC10, EC20), the highest no observed effect concentration (NOEC), the lowest observed effect concentration (LOEC), the benchmark 10 % (lower / upper) concentrations (BMC10, BMCL10, BMCU10) and a modelled non-toxic con-centration (NtC). These PoDs were then compared with serum and tissue concentrations de-termined from in vivo studies after treatment with therapeutic / supratherapeutic doses of the respective drugs in order to obtain a first estimate of risk based on in vitro data. In addition, AOPs were used to test whether the quantitative key event relationships between key events allow prediction of downstream effects and effects on the adverse outcome (AO) based on measurements of an early key event. Predictions of cytotoxicity from the mathematical rela-tionships showed good concordance with measured cytotoxicity after treatment with colistin and polymyxin b nonapeptide. The work also revealed uncertainties and limitations of the ap-plied strategy, which have a significant impact on the prediction and on a risk assessment based on in vitro results.